Home » Stocks » VRAY

ViewRay, Inc. (VRAY)

Stock Price: $3.70 USD -0.14 (-3.65%)
Updated December 1, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 549.45M
Revenue (ttm) 55.03M
Net Income (ttm) -117.02M
Shares Out 148.50M
EPS (ttm) -0.84
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 1
Last Price $3.70
Previous Close $3.84
Change ($) -0.14
Change (%) -3.65%
Day's Open 3.88
Day's Range 3.68 - 3.88
Day's Volume 1,076,359
52-Week Range 1.35 - 4.60

More Stats

Market Cap 549.45M
Enterprise Value 450.86M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 148.50M
Float n/a
EPS (basic) -0.87
EPS (diluted) -0.84
FCF / Share -0.44
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 14.89M
Short Ratio 17.38
Short % of Float n/a
Beta 0.81
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 9.98
PB Ratio 3.86
Revenue 55.03M
Operating Income -113.02M
Net Income -117.02M
Free Cash Flow -65.04M
Net Cash 98.58M
Net Cash / Share 0.66
Gross Margin 4.40%
Operating Margin -205.38%
Profit Margin -212.60%
FCF Margin -118.18%
ROA -26.30%
ROE -90.39%
ROIC -90.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (7)

Buy 4
Overweight 1
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$4.20*
(13.51% upside)
Low
4.00
Current: $3.70
High
5.00
Target: 4.20
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue87.7880.9634.0422.2410.396.403.16
Revenue Growth8.42%137.83%53.09%114.02%62.37%102.56%-
Gross Profit-5.486.606.33-3.63-4.15-2.75-5.03
Operating Income-121-75.09-48.16-44.18-41.43-31.58-27.10
Net Income-120-76.40-72.18-50.64-45.00-33.80-27.22
Shares Outstanding10281.1258.4640.0717.430.890.82
Earnings Per Share-1.18-0.98-1.23-1.26-2.58-37.87-34.59
Operating Cash Flow-79.57-122-70.05-28.16-39.85-27.47-25.37
Capital Expenditures-7.82-3.69-2.16-7.04-4.26-2.00-1.70
Free Cash Flow-87.38-126-72.22-35.20-44.10-29.47-27.07
Cash & Equivalents22816958.5315.3421.6112.18-
Total Debt68.2955.3644.5044.2929.0214.88-
Net Cash / Debt16011414.03-28.95-7.41-2.70-
Assets35029513648.7652.1634.11-
Liabilities13412813492.4259.1139.62-
Book Value2161671.99-43.65-6.96-151-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ViewRay, Inc.
Country United States
Employees 309
CEO Scott William Drake

Stock Information

Ticker Symbol VRAY
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: VRAY

Description

ViewRay designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.